External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

AMCP Nexus 2025

-
Coming soon
03:00 PM
Duration 60mins Maryland, United States
Two-Year Real-World Clinical Outcomes in Patients With Diabetic Macular Edema Treated With Faricimab▼ in the US: The FARETINA-DMEStudy
Ko S, Bonine N, Borkar D, Shaia J, Zwick E, Ali F, Leng T, Singh R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:00 PM
Duration 60mins Maryland, United States
FACTORS ASSOCIATED WITH VARIATION IN DRUG COSTS IN THE USA AND US STATES WITH PRESCRIPTION DRUG AFFORDABILITY BOARDS
Danny Sheinson, Thomas Majda, Will Wong, Zhiyu Xia

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:00 PM
Duration 60mins Maryland, United States
Impact of emicizumab on real-world healthcare resource utilization in the US
Janet Lee, Tu-My To, Robert Schuldt, Lucy Lee, Sanjay Ahuja

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Maryland, United States
Quantifying the productivity burden of lupus nephritis and the potential value of obinutuzumab treatment
Alexandra Miller, Kate Rosettie, Anisha M. Patel

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar